Skip to main content

Table 2 Patient and treatment characteristics of the safety population

From: A multi-center, prospective, open-label, 8-week study of certoparin for anticoagulation during maintenance hemodialysis – the membrane study

 

n = 109

Age

 Mean ± SD [years]

66.3 ± 14.7

 Median (range) [years]

71 (26-90)

 ≥ 65 years (n, %)

66 (60.6)

Male gender (%)

63 (57.8)

Weight

 Mean ± SD [kg]

82.5 ± 18.3

 Median (range) [kg]

81.1 (41-151.6)

Dialysis technique

 Hemodialysis (n, %)

99 (90.8)

 Hemodiafiltration (n, %)

10 (9.2)

Vascular access

 Arteriovenous fistula (%)

100 (91.7)

 Permanent dialysis catheter (%)

9 (8.3)

Exposure to certoparin

 Mean ± SD [days]

61.1 ± 33.9

 Median (range) [days]

57 (3-397)

Dialyses

 Mean ± SD [dialyses]

25.0 ± 4.2

 Median (range) [dialyses]

25 (2-32)

  1. SD, standard deviation.